The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals)_256_384.jpg)
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Subscribe To Our Newsletter & Stay Updated
